Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad ...

Q4 2024 Earnings Call Transcript February 28, 2025 Operator: Good morning ladies and gentlemen, and welcome to Companhia ...

First clinical data demonstrating robust confirmed responses and CNS anti-tumor activity for firmonertinib in first-line NSCLC EGFR PACC ...

Foreign, Commonwealth, and Development Office (FCDO), has formally unveiled the Nigeria Integrated Electricity Policy (NIEP) ...

Hello, everyone, and a warm welcome to the AES Corporation fourth quarter and full year 2024 financial review call. My name is Emily, and I'll be coordinating your call today. (Operator Instructions) ...

Good morning, and welcome to the Ecovyst Fourth Quarter 2024 Earnings Call. With me on the call this morning are Kurt Bitting, Ecovyst's Chief Executive Officer; and Mike Feehan, Ecovyst's Chief ...

Kevin Olsen; President, Chief Executive Officer, Director; Dorman Products Inc David Hession; Chief Financial Officer, Senior Vice President, Treasurer; Dorman Products Inc Thank you. Good morning ...

Interim 2025 Earnings Conference Call February 27, 2025 1:30 AM ET. Company Participants. Nico Muller - Chief Executive Officer Patr ...

This is the minimum amount which is required to buy "x" number of lots of a particular commodity to trade in futures market.

Whether its driving in cars, drinking clean water or going to school in a safely designed and constructed school building - ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today reported ...

OS Therapies (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate biopharmaceutical company, is pleased to invite investors to a webinar ...